The Toll-IL-1 receptor (TIR) domain-containing adaptor molecule-1 (TICAM-1, also called TRIF) is a signaling adaptor for TLR3 and TLR4 that activates the transcription factors IRF-3, NF-κB, and AP-1, leading to induction of type I IFN and cytokines. The N-terminal region of TICAM-1 participates in IRF-3 activation, while the C-terminal region is involved in NF-κB activation. However, the mechanism by which TICAM-1 is activated and transmits signals is largely unknown. In this study, we identified Leu 194 as a critical amino acid for TICAM-1-mediated IRF-3 activation. When Leu 
TICAM-1 is expressed at a low level in most tissues and cells and is diffusely localizes in the cytoplasm of resting cells (4, 12) . When endosomal TLR3 is activated by dsRNA, TICAM-1 transiently co-localizes with TLR3, then dissociates from the receptor and forms speckled structures that co-localize with downstream signaling molecules (12, 13 and a protease inhibitor cocktail (Roche)).
Lysates were pre-cleared with Protein G-Sepharose (GE Healthcare) and incubated with 0.5 µg anti-tag Abs or anti-TBK1 pAb subjected to native-PAGE (7.5% gel) as described (34) . Immunoblotting was performed using rabbit anti-human IRF-3 antibody and HRP-conjugated goat anti-rabbit
IgG.
Protein-protein interaction analysis
Protein-protein association in living cells was analyzed using the CoralHue showed no activity, and the R195A/S196A mutant had partially diminished activity (Fig.   2B , left panel). Other mutations had no effect on ability to activate the IFN-β promoter. R195A, S196A and S189A, and the combinations S189A/R195A and S189A/S196A, and examined the role of these residues in TICAM-1 signaling ( Fig. 2A) .
RESULTS

The TICAM-1 N-terminus from Gly
Remarkably 
IRF-3 activation
The L194A mutant did not activate the IFN-β promoter, even though its expression was comparable to wild-type TICAM-1 (Fig.  3A) . The promoter of the human IFN-β gene possesses binding sites for IRF-3, NF-κB and AP-1 (25), so we examined which activation pathways were affected by mutation of Leu 194 .
As shown in Figure 3B , substitution of Leu with both wild-type and the L194A mutant (Fig. 4A) . However, the IRF-3 kinase TBK1
did not colocalize with the L194A mutant.
The lack of association between the L194A mutant and endogenous TBK1 was also observed in TLR3-mediated activation.
Wild-type and the L194A mutant diffusely localized in cytoplasm when expressed at a low level (Fig. 4B ). After poly(I:C) stimulation, wild-type TICAM-1 formed a speckle-like signalosome where endogenous TBK1 co-localized (Fig. 4B, left panels) . In contrast, the L194A mutant did not recruit TBK1 to its signalosome (Fig. 4B, A TICAM-1 mutant lacking the NTD (Δ180) had high potential to activate the IFN-β promoter compared to wild-type TICAM-1 (Fig. 1C) . This augmented activity of Δ180 mutant was more clearly shown when wild-type or Δ180 mutant was expressed at a low level (Fig. 7A) . In 2A were subjected to SDS-PAGE (7.5% gel) followed by immunoblotting with anti-HA pAb. S Q G C S L R S T G S P S193A L194A R195A S196A S189A S189A/R195A S189A/S196A WT G191A/C192A S193A/L194A R195A/S196A T197A/G198A S199A/P200A vector WT S193A/L194A S193A L194A vector WT R195A/S196A R195A S196A S189A S189A/R195A S189A/S196A
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